Bevacizumab may be active in myelofibrosis.
Nikolaidis I, Makrilia N, Xyla V, Dilana K, Stathopoulos D, Meletis I, Syrigos K.
Nikolaidis I, et al. Among authors: meletis i.
Cancer Invest. 2010 Jan;28(1):111-2. doi: 10.3109/07357900902918502.
Cancer Invest. 2010.
PMID: 20001298